Rafarma Pharmaceuticals Market Cap

Rafarma Pharmaceuticals has a market cap or net worth of $4.91 million as of June 25, 2025. Its market cap has decreased by -74.55% in one year.

Market Cap

4.91M

Enterprise Value

n/a

Revenue

133.33K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.06

Market Cap Chart

Since October 18, 2012, Rafarma Pharmaceuticals's market cap has decreased from 20.34M to 4.91M, a decrease of -75.84%. That is a compound annual growth rate of -10.59%.

Market Cap History

Date	Market Cap	% Change
Jun 24, 2025	4.91M	-27.51%
Dec 31, 2024	6.78M	-70.44%
Dec 29, 2023	22.93M	-40.44%
Dec 30, 2022	38.51M	-47.44%
Dec 31, 2021	73.26M	-47.17%
Dec 31, 2020	138.67M	273.04%
Dec 31, 2019	Pro	Pro
Dec 27, 2018	Pro	Pro
Dec 27, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.59B
Elite Pharmaceuticals	792.66M
Veradigm	764.23M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
American Oncology Network	435.36M
Glass House Brands	393.08M
CytoDyn	387.16M

Market Cap Rankings